Jia Li

Dr. Jia Li

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2020 in The Journal of Spinal Cord Medicine
Verified
Journal Article
Closed access
JLJia Li
Jia Li
WPWilliam Van Der Pol
William Van Der Pol
MEMualla Eraslan
Mualla Eraslan
AMAmie McLain
Amie McLain
HÇHATİCE ÇETİN
HATİCE ÇETİN
CYCeren Yarar-Fisher
Ceren Yarar-Fisher
Objective: Compare the gut microbiome composition among individuals with acute spinal cord injury (A-SCI), long-standing SCI (L-SCI), vs. able-bodied (AB) controls. Design: Cross-sectional study. Setting: The University of Alabama at Birmingham. Participants: Seven adults with A-SCI (36 ± 12 years, 2F/5M, C4-T10, and American Spinal Injury Association Impairment Scale [AIS] A–D), 25 with L-SCI (46 ± 13 years, 6F/19M, C4-L1, and AIS A–D), and 25 AB controls (42 ± 13 years, 9F/16M). Methods: Stool samples were collected after a median of 7 days and 18 years after injury in the A-SCI and L-SCI groups, respectively. Gut microbiome composition was analyzed using the 16S rRNA sequencing technique and QIIME software. The abundances of bacteria communities among groups were compared using the Kruskal–Wallis test adjusted for age. Results: Several alpha diversity indices were different among groups (Chao1, Observed species, and Phylogenetic Diversity), but not others (Shannon and Simpson). Beta diversity differed among each pair of groups (P < 0.05). A number of microbial communities were differentially abundant among the groups (P < 0.05). Conclusion: Our results revealed differences in the gut microbiome composition among groups. Compared to the AB controls, the SCI groups demonstrated microbiome profiles that shared features linked to metabolic syndrome, inflammation-related bowel disorders, depressive disorders, or antibiotics use, whereas the L-SCI group’s microbiome included features linked to reduced physical activity compared to the A-SCI and AB controls. Our results provided preliminary data and a scientific foundation for future studies investigating the impact of the gut microbiome composition on long-term health in individuals with SCI.

10 April 2022 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
JLJia Li
Jia Li
CMCasey Morrow
Casey Morrow
AMAmie McLain
Amie McLain
EWErika D. Womack
Erika D. Womack
CYCeren Yarar-Fisher
Ceren Yarar-Fisher

11 January 2021 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
CYCeren Yarar-Fisher
Ceren Yarar-Fisher
JLJia Li
Jia Li
EWErika D Womack
Erika D Womack
AAAmal Alharbi
Amal Alharbi
OSOscar Seira
Oscar Seira
WTWolfram Tetzlaff
Wolfram Tetzlaff

1 April 2022 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
JLJia Li
Jia Li
CMCasey Morrow
Casey Morrow
SBStephen Barnes
Stephen Barnes
LWLandon Wilson
Landon Wilson
EWErika D. Womack
Erika D. Womack
CYCeren Yarar-Fisher
Ceren Yarar-Fisher

21 November 2022 in Physiological Reports
Verified
Journal Article
Open access
JLJia Li
Jia Li
BGBarbara Gower
Barbara Gower
AMAmie McLain
Amie McLain
CYCeren Yarar-Fisher
Ceren Yarar-Fisher
We explored the impact of a low‐carbohydrate/high‐protein diet (LC/HP, ~30% energy from protein, 40% energy from carbohydrate) on indices of metabolic function and body composition in individuals with chronic spinal cord injury (SCI). Adults with SCI (≥3 years post‐injury, C4‐L2, AIS A‐D) and insulin resistance or pre‐diabetes were randomly assigned to an 8‐week iso‐caloric LC/HP diet group (n = 11) or control group (n = 14). All LC/HP meals were delivered weekly to participants' homes, and participants in the control group consumed their habitual diet. Each participant underwent an oral glucose tolerance test (OGTT) to assess glucose tolerance, insulin, area under the curve (AUC) for glucose and insulin, Matsuda Index, glucose‐stimulated insulin secretion (GSIS), disposition index, and hepatic insulin extraction (HIE). Fasting blood lipid and inflammation were assessed, and body composition was estimated using dual‐energy x‐ray absorptiometry. A linear mixed model was used to evaluate the main effect of diet, time, and their interaction. Compared to the control group, participants in the LC/HP group had reduced total body fat mass (LC/HP: −5.9%, Control: 0.7%), visceral fat mass (LC/HP: −16.2%, Control: 5.2%), total‐ (LC/HP: −20.1, Control: 3.7 mg/dl), and LDL‐cholesterol (LC/HP: −13.9, Control: 3.1 mg/dl) (pdiet*time < 0.05 for all). Regardless of group, AUCinsulin and peak insulin during the OGTT decreased, and HIE increased over time (ptime < 0.05). A trend for diet*time interaction was observed for glucoseOGTT120min (LC/HP: −20.7, Control: 3.0 mg/dl, pdiet*time = 0.09) and peak C‐peptide (LC/HP: −2.1, Control: 0.0 ng/ml, pdiet*time = 0.07). HDL‐cholesterol, lean body mass, Matsuda Index, fasting glucose, insulin, insulinOGTT120min, AUCglucose, pancreatic beta cell function (GSIS, disposition index), and inflammation (C‐reactive protein, IL‐6, IL‐8, IL‐10, TNF‐α) did not change over time. In conclusion, our results suggest that individuals with SCI and insulin resistance may adopt an LC/HP diet to improve body composition and lipid profiles. Its impact on glucose metabolism and inflammation remains inconclusive and warrants future investigations.

30 July 2019 in Trials
Verified
Journal Article
Open access
PDF file
CYCeren Yarar-Fisher
Ceren Yarar-Fisher
JLJia Li
Jia Li
AMAmie McLain
Amie McLain
BGBarbara Gower
Barbara Gower
RORobert Alan Oster
Robert Alan Oster
CMCasey Morrow
Casey Morrow
Metabolic disorders (e.g., impaired glucose tolerance, insulin resistance, and type 2 diabetes) are more prevalent in people with spinal cord injury (SCI) than able-bodied individuals. Dietary modification is a more cost-effective treatment option than pharmacological therapies for reducing the risk of metabolic dysfunction. Lowering carbohydrate, increasing protein, and maintaining a proper dietary fat intake are expected to induce favorable adaptations in glucose control, body fat distribution, and the composition of the gut microbiome. However, dietary modification has not been rigorously investigated in people with SCI. The purpose of this study is to determine if an 8-week low-carbohydrate/high-protein (LC/HP) dietary intervention will show improvements in clinically important metrics of metabolic function, body composition, the composition of gut bacteria, and quality of life. We intend to recruit 100 participants with chronic traumatic SCI (3 years postinjury, C5–L2, American Spinal Injury Association impairment scale A–D, and aged 18–65 years) and insulin resistance, impaired glucose tolerance or untreated type 2 diabetes and randomly assign them to an 8-week LC/HP dietary intervention group or a control group. The daily LC/HP dietary intervention includes ~ 30% total energy as protein (1.6 g/kg per day) with a carbohydrate-to-protein ratio < 1.5 and fat intake set at ~ 30% of the total energy intake. The control group does not receive any dietary intervention and are continuing with their regular daily diets. Glucose tolerance, insulin sensitivity, β-cell function, body composition, gut microbiome composition, and quality of life measures are assessed at week 1, before starting the LC/HP dietary intervention, and at week 8, after completion of the LC/HP dietary intervention. New information derived from this project will result in the development of a low-cost, simple, self-administered LC/HP dietary intervention for improving metabolic function in individuals with chronic SCI, improved understanding of the composition of gut bacteria in SCI, and how a LC/HP dietary intervention alters gut bacteria composition. In addition, this project will improve our understanding of the relationship between metabolic function and quality of life in individuals with long-standing SCI. ClinicalTrials.gov, NCT03207841. Registered on 5 June 2017.